69 Health Tech Startups in London to Watch in 2024
How do we build this list?
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Antibody-Drug Conjugate specialist creating treatments for tough-to-treat cancers. |
$120M · Series B | TCG Crossover, Atlas Ventures, Brandon Capital | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma | B2B | London, UK | •••••••••••@pheontx.com | |
Provider of single and multi-organ microphysiological systems. |
$21M · Series B | CN Innovations | 101 to 250 | Health Tech, Biotech | London, UK | •••••••••••@cn-bio.com | ||
Biomedical research discovery tool. |
$60M · Series B | ICONIQ Growth, Index Ventures, Pentech Ventures | 51 to 100 | Health Tech, AI, Biotech, Pharma | B2B, SaaS | London, UK | •••••••••••@causaly.com | |
Skin care telehealth platform. |
$52M · Series B | Village Global, Index Ventures, Headline | 101 to 250 | Health Tech | B2C | London, UK | •••••••••••@getharley.com | |
Oophthalmic gene therapy company to treat blinding retinal illnesses. |
$120M · Series A | Syncona Partners LLP | 1 to 10 | Health Tech, Biotech | London, UK | •••••••••••@beacontx.com | ||
Virtual reality healthcare training platform. |
$12M · Series A | Frog Capital, ACF Investors, QVentures | 1 to 10 | Health Tech, Edtech | B2B, SaaS | London, UK | •••••••••••@oxfordmedicalsimulation.com | |
AI-powered platform for Alzheimer and dementia patients. |
$700k · Pre Seed | Abac Nest, Fondo Bolsa Social, Heartfelt | 1 to 10 | Health Tech, AI | B2C, SaaS | London, UK | •••••••••••@puntohealth.com | |
Developer of non-biological affinity reagents to accelerate the production of cell and gene therapies. |
$8M · Series A | Mercia Asset Management | 11 to 50 | Health Tech, Biotech | London, UK | •••••••••••@mipdiscovery.com | ||
AI platform to map the human immune system. |
$14M · Series A | Molten Ventures, Life Extension Ventures | 11 to 50 | Health Tech, Biotech | London, UK | •••••••••••@imubiosciences.com | ||
Workflow automation platform for the life sciences industry. |
$40M · Series B | Local Globe, A.P. Moller Holding, Dimension | 51 to 100 | Health Tech, Machine Learning | B2B | London, UK | •••••••••••@automata.tech | |
Technology-enabled company providing home care services in London. |
$64M | Oltre Venture | 5001 to 10000 | Health Tech, Mobile, Service Industry, ElderTech | B2B, B2C | London, UK | •••••••••••@ceracare.co.uk | |
Digital health platform for predictive care and research. |
$80M · Series D | Hitachi Ventures, Unilever Ventures, Samsung NEXT | 101 to 250 | Health Tech, AI | B2B, SaaS | London, UK | •••••••••••@huma.com | |
Generative AI platform for doctors. |
$4M · Seed | Khosla Ventures, Entrepreneur First | 1 to 10 | Health Tech, AI | B2B, SaaS | London, UK | •••••••••••@tortus.ai | |
Clinical trials platform. |
$18M · Series A | Valar Ventures, Creandum, Seedcamp | 11 to 50 | Health Tech, Biotech | B2B, SaaS | London, UK | •••••••••••@lindushealth.com | |
User-owned genomics database platform. |
$20M · Series A | GEM Digital | 1 to 10 | Health Tech, Biotech | B2C | London, UK | •••••••••••@genomes.io | |
At-home blood testing platform for cancer patients. |
$17M · Series A | Business Growth Fund, Parkwalk Advisors | 11 to 50 | Health Tech | B2B | London, UK | •••••••••••@entia.co | |
Fertility treatment for employees. |
$6M · Seed | Notion Capital, Passion Capital, Tiny VC | 1 to 10 | Health Tech | B2B | London, UK | •••••••••••@fertifa.com | |
Cell therapy firm specializing in developing treatments using advanced cellular technology. |
$45M · Series A | AlbionVC, Point72 Ventures | 101 to 250 | Health Tech, Edtech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@quell-tx.com | |
We’re going where no-one has ever gone before. -- We’re fighting cancer. -- Lives are at stake. |
$22M · Series A | Hoxton Ventures, Atomico, Connect Ventures | 11 to 50 | Health Tech, AI | B2B | London, UK | •••••••••••@kheironmed.com | |
Platform to automate the clinical studies process. |
$12M · Series A | Playfair, Delin Ventures, 11.2 Capital | 11 to 50 | Health Tech, Biotech | B2B | London, UK | •••••••••••@umed.io | |
Platform using deep learning on 3D molecular structures to develop treatments for harmful proteins. |
$50M · Series A | Khosla Ventures, General Catalyst | 1 to 10 | Health Tech, AI, Biotech, Data and Analytics | B2B | London, UK | •••••••••••@charmtx.com | |
Gene silencing platform for the creation of programmable, allogeneic cell therapies. |
$16M · Seed | Mercia Asset Management, Calculus Capital, UK Innovation & Science Seed Fund | 1 to 10 | Health Tech, Biotech | London, UK | •••••••••••@laverocktx.com | ||
Digital health platform. |
$1M · Seed | Aviva Ventures | 1 to 10 | Health Tech | B2B, SaaS | London, UK | •••••••••••@healthkey.health | |
Manufacturing platform designed to help patients access lifesaving treatments. |
$30M · Series A | Kindred Capital, Octopus Ventures, Amadeus Capital | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@oribiotech.com | |
Behavior change platform digitizing the treatment of type 2 diabetes and obesity. |
$21M · Series B | Earlybird Venture Capital, AlbionVC, Partech Ventures | 251 to 500 | Health Tech, Foodtech, CPG & Consumer Goods, Ecommerce | B2B | London, UK | •••••••••••@oviva.com | |
Biotechnology firm developing antiviral treatments for patients. |
$44M · Series C | Novo A/S, Andera Partners | 11 to 50 | Health Tech, Biotech, Pharma | B2B | London, UK | •••••••••••@reviral.co.uk | |
Gynecological health company creating products and services for vaginal treatment. |
$5M · Seed | Khosla Ventures, Index Ventures, Kindred Capital | 11 to 50 | Health Tech, Biotech, Manufacturing, Ecommerce, Cannabis | B2C | London, UK | •••••••••••@yourdaye.com | |
Biotechnology firm focused on advancing RNA therapies. |
$10M | Y Combinator, Pi Campus | 11 to 50 | Health Tech, Biotech, Robotics, Manufacturing, Business Intelligence | B2B | London, UK | •••••••••••@sixfold.bio | |
Digital hospital of the future, providing elective medical procedures with a fully-digitised, personal and patient-first experience. |
$7M · Series A | Talis Capital, Cavalry Ventures Management, Signals Venture Capital | 11 to 50 | Health Tech | B2C, Marketplace | London, UK | •••••••••••@medbelle.com | |
AI-powered service screens for melanoma skin cancer. |
$5M · Series A | Hoxton Ventures | 11 to 50 | Health Tech, AI, Data and Analytics, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@skin-analytics.com | |
A service providing at-home finger-prick blood tests to help individuals monitor and enhance their health. |
$7M · Series A | Target Global, Pembroke VCT | 101 to 250 | Health Tech, Consumer Social, Media and Entertainement, Ecommerce | B2C | London, UK | •••••••••••@thriva.co | |
Platform offering diagnostic tools and testing to aid patients in making health-related decisions. |
$6M · Seed | Felix Capital, Cherry Ventures, FJ Labs | 11 to 50 | Health Tech, Fashion, Pharma, Mobile, Ecommerce | B2C | London, UK | •••••••••••@manual.co | |
Soft modular prosthetics maker for below-elbow limb. |
$1M · Seed | British Design Fund | 1 to 10 | Health Tech, Manufacturing | B2C | London, UK | •••••••••••@yourkoalaa.com | |
Platform for booking beauty and wellness appointments with local businesses. |
$20M · Series B | Partech Ventures, Target Global, FJ Labs | 251 to 500 | Health Tech, Fashion, Ecommerce | B2B, B2C, SaaS | London, UK | •••••••••••@fresha.com | |
Healthtech and electrical distribution company specializing in advanced air purification solutions. |
$7M · Series A | Hoxton Ventures | 11 to 50 | Health Tech, Hardware, Manufacturing | B2B | London, UK | •••••••••••@rensair.com | |
AI-driven mental health assessment platform. |
$2M · Seed | Entrepreneur First, Kodori AG, Form Ventures | 1 to 10 | Health Tech, AI | SaaS | London, UK | •••••••••••@thymia.ai | |
Digital healthcare program for people with ADHD. |
$11M · Series A | Hoxton Ventures, Octopus Ventures, Y Combinator | 11 to 50 | Health Tech, Mobile | B2C | London, UK | •••••••••••@getinflow.io | |
Platform that offers immersive virtual reality fitness classes to make exercise engaging and accessible. |
$7M | Hiro Capital | 51 to 100 | Health Tech, Gaming, AR / VR, Sportstech, Fitness | B2C, SaaS | London, UK | •••••••••••@fitxr.com | |
Platform enabling seamless communication for healthier patients and happier healthcare staff. |
$11M · Series A | Local Globe, Latitude, Atomico | 101 to 250 | Health Tech | B2B, SaaS | London, UK | •••••••••••@accurx.com | |
AI-driven financial management platform for hospitals. |
$3M · Seed | General Catalyst, Bertelsmann Investments, KHP Ventures | 1 to 10 | Health Tech, Fintech | B2B, SaaS | London, UK | •••••••••••@phare.health | |
Health and quality inspection platform. |
$5M · Series A | octopus investments | 11 to 50 | Health Tech, Deep Tech, Robotics, Manufacturing | B2B, SaaS | London, UK | •••••••••••@perfectward.com | |
Clear aligner orthodontics. |
$2M · Seed | Balderton Capital | 11 to 50 | Health Tech | B2C | London, UK | •••••••••••@32co.com | |
Drug discovery platform focused on developing small molecule inhibitors. |
$6M · Seed | Sofinnova Partners | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | London, UK | •••••••••••@myricxpharma.com | |
Cancer treatment predictor software. |
$14M · Series A | Hoxton Ventures, Octopus Ventures, Fly Ventures | 11 to 50 | Health Tech, Biotech, Pharma | B2B | London, UK | •••••••••••@pearbio.com | |
At-home fertility treatment. |
$3M · Seed | Octopus Ventures, Calm/Storm Ventures, QVentures | 1 to 10 | Health Tech, Biotech | B2C | London, UK | •••••••••••@beafertility.com | |
AR therapy for Parkinson's disease. |
$2M · Seed | SFC Capital, Kluz Ventures, Midlands Engine Investment Fund | 11 to 50 | Health Tech, AR / VR | B2C | London, UK | •••••••••••@strolll.co | |
Technology company focused on health and wellbeing solutions. |
$14M · Series A | Target Global, VNV Global | 501 to 1000 | Health Tech, Mobile | B2B, B2C | London, UK | •••••••••••@palta.com | |
Technology system designed for the medicine and aviation sectors. |
$8M · Series A | LG Capital | 11 to 50 | Health Tech, Space Tech, Mobility & Transportation, Manufacturing | B2B | London, UK | •••••••••••@caelinova.com | |
Digital triage platform providing services to the NHS. |
$9M · Series A | Calculus Capital, Gresham House Ventures | 101 to 250 | Health Tech, Edtech | B2B, Marketplace | London, UK | •••••••••••@econsult.net | |
Flo is an AI-powered women’s health app that supports women at every stage of their reproductive cycle. |
$200M · Series C | General Atlantic, Target Global, VNV Global | 251 to 500 | Health Tech, Mobile | B2C, SaaS | London, UK | •••••••••••@flo.health | |
Marketplace connecting vacant care home shifts with local nurses and carers seeking extra work. |
$6M · Series A | AXA Venture Partners | 51 to 100 | Health Tech, Hiring and Recruitement, ElderTech | B2B, B2C, Marketplace | London, UK | •••••••••••@florence.co.uk | |
AI-Powered healthcare platform. |
$5M · Seed | Hoxton Ventures, eHealth Ventures, JamJar Investments | 1001 to 5000 | Health Tech, AI | B2B, B2C | London, UK | •••••••••••@babylonhealth.com | |
Pathfinder is developing a novel catheter based system that provides a better way for patients to receive haemodialysis for kidney failure. |
$11M · Series A | Business Growth Fund, Deepbridge Capital, Parkwalk Advisors | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@pathfindermed.com | |
Startup focused on addressing erectile dysfunction. |
$12M · Series A | Anthemis, VNV Global | 11 to 50 | Health Tech, Edtech | B2C | London, UK | •••••••••••@numan.com | |
Precision software for eye surgery. |
$8M · Seed | Redalpine | 1 to 10 | Health Tech, Biotech | London, UK | •••••••••••@hypervisionsurgical.com | ||
Patient management platform. |
$12M · Series B | YFM Equity Partners | 11 to 50 | Health Tech | London, UK | •••••••••••@drdoctor.co.uk | ||
Review platform for healthcare. |
$10M · Series A | Beringea, Keen Venture Partners, Amadeus Capital | 51 to 100 | Health Tech, Identity Management | B2B, B2C, Marketplace | London, UK | •••••••••••@doctify.com | |
Fitness game developers. |
$9M · Series A | Heartcore, Khosla Ventures, Tencent | 11 to 50 | Health Tech, Gaming, Sportstech, Fitness, Manufacturing | B2C | London, UK | •••••••••••@playquell.com | |
Quantum simulation platform for drug discovery. |
$2M · Seed | Ascension Ventures, ACF Investors | 1 to 10 | Health Tech, Biotech | B2B, SaaS | London, UK | •••••••••••@kuano.ai | |
Healthcare provider specializing in incontinence awareness and breaking bladder taboos. |
$4M · Seed | Eka Ventures, Joyance Partners, Samos Investments | 11 to 50 | Health Tech, Manufacturing, Ecommerce | B2C | London, UK | •••••••••••@wearejude.com | |
Therapy and coaching platform. |
$20M · Series B | Omers Ventures, Octopus Ventures | 51 to 100 | Health Tech, Fitness | B2B, B2C, Marketplace | London, UK | •••••••••••@helloself.com | |
Immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer. |
$17M · Seed | AlbionVC, Boxer Capital, Syncona Partners LLP | 101 to 250 | Health Tech, Biotech | B2B | London, UK | •••••••••••@achillestx.com | |
Supplier of medical cannabis care and medicine. |
$6M · Series A | Leafy Tunnel | 51 to 100 | Health Tech, Agritech, Pharma, Manufacturing, Cannabis | B2B | London, UK | •••••••••••@LYPHEGROUP.com | |
Platform for capturing patient data for research in an engaging and scalable way. |
$6M · Series A | AlbionVC | 51 to 100 | Health Tech, Data and Analytics, Creative Tools | B2B, SaaS | London, UK | •••••••••••@umotif.com | |
Diagnostic imaging platform. |
$12M · Series A | Triple Point Ventures | 51 to 100 | Health Tech | London, UK | •••••••••••@scan.com | ||
Platform dedicated to transforming reproductive health. |
$5M · Seed | Local Globe | 11 to 50 | Health Tech | B2B, B2C | London, UK | •••••••••••@hertilityhealth.com | |
Digital mental health platform for employees. |
$2M · Series A | IW Capital | 51 to 100 | Health Tech | B2B, SaaS | London, UK | •••••••••••@plummhealth.com | |
SaaS platform offering psychometric tests for hiring and recruitment. |
$3M | Octopus Ventures | 51 to 100 | Health Tech, Hiring and Recruitement | B2B, SaaS | London, UK | •••••••••••@sovaassessment.com | |
Virtual program that helps people prepare mind and body for surgery through sustainable lifestyle changes. |
$2M | TrueSight Ventures, Charlotte Street Capital | 1 to 10 | Health Tech, Consumer Social | B2B, B2C, SaaS | London, UK | •••••••••••@surgeryhero.com |
Sign up to access our full database
Enter your email and get access to 18,000+ technology companies you can partner with.